• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄激素对雄激素受体共调节因子的调控。

Androgen regulation of the androgen receptor coregulators.

作者信息

Urbanucci Alfonso, Waltering Kati K, Suikki Hanna E, Helenius Merja A, Visakorpi Tapio

机构信息

Institute of Medical Technology, University of Tampere and Tampere University Hospital, FI-33014 University of Tampere, Tampere, Finland.

出版信息

BMC Cancer. 2008 Aug 1;8:219. doi: 10.1186/1471-2407-8-219.

DOI:10.1186/1471-2407-8-219
PMID:18673534
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2518564/
Abstract

BACKGROUND

The critical role of the androgen receptor (AR) in the development of prostate cancer is well recognized. The transcriptional activity of AR is partly regulated by coregulatory proteins. It has been suggested that these coregulators could also be important in the progression of prostate cancer. The aim of this study was to identify coregulators whose expression is regulated by either the androgens and/or by the expression level of AR.

METHODS

We used empty vector and AR cDNA-transfected LNCaP cells (LNCaP-pcDNA3.1, and LNCaP-ARhi, respectively), and grew them for 4 and 24 hours in the presence of dihydrotestosterone (DHT) at various concentrations. The expression of 25 AR coregulators (SRC1, TIF2, PIAS1, PIASx, ARIP4, BRCA1, beta-catenin, AIB3, AIB1, CBP, STAT1, NCoR1, AES, cyclin D1, p300, ARA24, LSD1, BAG1L, gelsolin, prohibitin, JMJD2C, JMJD1A, MAK, PAK6 and MAGE11) was then measured by using real-time quantitative RT-PCR (Q-RT-PCR).

RESULTS

Five of the coregulators (AIB1, CBP, MAK, BRCA1 and beta-catenin) showed more than 2-fold induction and 5 others (cyclin D1, gelsolin, prohibitin, JMJD1A, and JMJD2C) less than 2-fold induction. Overexpression of AR did not affect the expression of the coregulators alone. However, overexpression of AR enhanced the DHT-stimulated expression of MAK, BRCA1, AIB1 and CBP and reduced the level of expression of beta-catenin, cyclinD1 and gelsolin.

CONCLUSION

In conclusion, we identified 5 coactivators whose expression was induced by androgens suggesting that they could potentiate AR signaling. Overexpression of AR seems to sensitize cells for low levels of androgens.

摘要

背景

雄激素受体(AR)在前列腺癌发生发展中的关键作用已得到充分认识。AR的转录活性部分受共调节蛋白调控。有人提出这些共调节因子在前列腺癌进展中也可能起重要作用。本研究的目的是鉴定其表达受雄激素和/或AR表达水平调控的共调节因子。

方法

我们使用空载体和AR cDNA转染的LNCaP细胞(分别为LNCaP-pcDNA3.1和LNCaP-ARhi),并在不同浓度的二氢睾酮(DHT)存在下培养4小时和24小时。然后使用实时定量RT-PCR(Q-RT-PCR)检测25种AR共调节因子(SRC1、TIF2、PIAS1、PIASx、ARIP4、BRCA1、β-连环蛋白、AIB3、AIB1、CBP、STAT1、NCoR1、AES、细胞周期蛋白D1、p300、ARA24、LSD1、BAG1L、凝溶胶蛋白、抑制素、JMJD2C、JMJD1A、MAK、PAK6和MAGE11)的表达。

结果

5种共调节因子(AIB1、CBP、MAK、BRCA1和β-连环蛋白)显示出超过2倍的诱导,另外5种(细胞周期蛋白D1、凝溶胶蛋白、抑制素、JMJD1A和JMJD2C)诱导倍数小于2倍。AR的过表达单独不影响共调节因子的表达。然而,AR的过表达增强了DHT刺激的MAK、BRCA1、AIB1和CBP的表达,并降低了β-连环蛋白、细胞周期蛋白D1和凝溶胶蛋白的表达水平。

结论

总之,我们鉴定出5种共激活因子,其表达受雄激素诱导,提示它们可能增强AR信号传导。AR的过表达似乎使细胞对低水平雄激素敏感。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c8f/2518564/03d02a0f0561/1471-2407-8-219-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c8f/2518564/c42ffb2b337e/1471-2407-8-219-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c8f/2518564/de9c505a29ed/1471-2407-8-219-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c8f/2518564/3d493f79f6ff/1471-2407-8-219-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c8f/2518564/03d02a0f0561/1471-2407-8-219-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c8f/2518564/c42ffb2b337e/1471-2407-8-219-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c8f/2518564/de9c505a29ed/1471-2407-8-219-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c8f/2518564/3d493f79f6ff/1471-2407-8-219-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c8f/2518564/03d02a0f0561/1471-2407-8-219-4.jpg

相似文献

1
Androgen regulation of the androgen receptor coregulators.雄激素对雄激素受体共调节因子的调控。
BMC Cancer. 2008 Aug 1;8:219. doi: 10.1186/1471-2407-8-219.
2
Expression of androgen receptor coregulators in prostate cancer.雄激素受体共调节因子在前列腺癌中的表达
Clin Cancer Res. 2004 Feb 1;10(3):1032-40. doi: 10.1158/1078-0432.ccr-0990-3.
3
Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.雄激素受体表达增加使前列腺癌细胞对低水平雄激素敏感。
Cancer Res. 2009 Oct 15;69(20):8141-9. doi: 10.1158/0008-5472.CAN-09-0919. Epub 2009 Oct 6.
4
Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription.雄激素受体共调节因子转录的细胞系和组织特异性特征
J Mol Med (Berl). 2006 Nov;84(11):919-31. doi: 10.1007/s00109-006-0081-1. Epub 2006 Aug 24.
5
MiR137 is an androgen regulated repressor of an extended network of transcriptional coregulators.微小RNA137是雄激素调节的转录共调节因子扩展网络的一种阻遏物。
Oncotarget. 2015 Nov 3;6(34):35710-25. doi: 10.18632/oncotarget.5958.
6
Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.前列腺癌中由于雄激素反应丧失导致 Akt 信号转导增加。
Curr Med Chem. 2013;20(1):144-57.
7
AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.雄激素受体对 AIB1 的隔离抑制了乳腺癌细胞中雌激素依赖性细胞周期蛋白 D1 的表达。
BMC Cancer. 2019 Nov 4;19(1):1038. doi: 10.1186/s12885-019-6262-4.
8
Bone stroma-derived cells change coregulators recruitment to androgen receptor and decrease cell proliferation in androgen-sensitive and castration-resistant prostate cancer cells.骨基质衍生细胞改变共调节因子对雄激素受体的募集,并降低雄激素敏感和去势抵抗性前列腺癌细胞的增殖。
Biochem Biophys Res Commun. 2015 Nov 27;467(4):1039-45. doi: 10.1016/j.bbrc.2015.10.009. Epub 2015 Oct 20.
9
Dihydrotestosterone interacts with EGFR/MAPK signalling and modulates EGFR levels in androgen receptor-positive LNCaP prostate cancer cells.双氢睾酮与表皮生长因子受体/丝裂原活化蛋白激酶信号通路相互作用,并调节雄激素受体阳性的LNCaP前列腺癌细胞中的表皮生长因子受体水平。
Int J Oncol. 2008 Sep;33(3):623-9.
10
TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.转化生长因子-β信号传导和雄激素受体状态决定了人类前列腺癌细胞中的凋亡串扰。
Prostate. 2008 Feb 15;68(3):287-95. doi: 10.1002/pros.20698.

引用本文的文献

1
Detection of Cancer-Associated Gene Mutations in Urinary Cell-Free DNA among Prostate Cancer Patients in South Africa.南非前列腺癌患者尿游离 DNA 中与癌症相关的基因突变检测。
Genes (Basel). 2023 Sep 27;14(10):1884. doi: 10.3390/genes14101884.
2
Unravelling the Role of Kinases That Underpin Androgen Signalling in Prostate Cancer.揭示激酶在前列腺癌中支撑雄激素信号的作用。
Cells. 2022 Mar 10;11(6):952. doi: 10.3390/cells11060952.
3
BRCA Mutations in Prostate Cancer: Assessment, Implications and Treatment Considerations.BRCA 基因突变与前列腺癌:评估、影响及治疗策略考量。

本文引用的文献

1
Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer.睾酮抑制后前列腺内雄激素及雄激素调节的基因表达持续存在:对去势抵抗性前列腺癌的治疗意义
Cancer Res. 2007 May 15;67(10):5033-41. doi: 10.1158/0008-5472.CAN-06-3332.
2
Androgen receptor coregulators and their involvement in the development and progression of prostate cancer.雄激素受体共调节因子及其在前列腺癌发生发展中的作用
Int J Cancer. 2007 Feb 15;120(4):719-33. doi: 10.1002/ijc.22365.
3
Androgen receptor corepressors and prostate cancer.
Int J Mol Sci. 2021 Nov 23;22(23):12628. doi: 10.3390/ijms222312628.
4
Systematic Review and Meta-Analysis of Lysine-Specific Demethylase 1 Expression as a Prognostic Biomarker of Cancer Survival and Disease Progression.赖氨酸特异性去甲基化酶1表达作为癌症生存和疾病进展的预后生物标志物的系统评价和荟萃分析
Cancer Control. 2021 Jan-Dec;28:10732748211051557. doi: 10.1177/10732748211051557.
5
The Urinary Transcriptome as a Source of Biomarkers for Prostate Cancer.尿转录组作为前列腺癌生物标志物的来源
Cancers (Basel). 2020 Feb 22;12(2):513. doi: 10.3390/cancers12020513.
6
The deubiquitinase USP38 affects cellular functions through interacting with LSD1.去泛素化酶 USP38 通过与 LSD1 相互作用影响细胞功能。
Biol Res. 2018 Nov 29;51(1):53. doi: 10.1186/s40659-018-0201-8.
7
The Divergent Function of Androgen Receptor in Breast Cancer; Analysis of Steroid Mediators and Tumor Intracrinology.雄激素受体在乳腺癌中的不同功能;类固醇介质与肿瘤内分泌学分析
Front Endocrinol (Lausanne). 2018 Oct 26;9:594. doi: 10.3389/fendo.2018.00594. eCollection 2018.
8
Up-regulated and interrelated expressions of GINS subunits predict poor prognosis in hepatocellular carcinoma.GINS 亚基的上调和相互关联的表达可预测肝细胞癌的不良预后。
Biosci Rep. 2018 Dec 7;38(6). doi: 10.1042/BSR20181178. Print 2018 Dec 21.
9
KDM1A microenvironment, its oncogenic potential, and therapeutic significance.KDM1A 微环境、其致癌潜能及治疗意义。
Epigenetics Chromatin. 2018 Jun 19;11(1):33. doi: 10.1186/s13072-018-0203-3.
10
Profiling Prostate Cancer Therapeutic Resistance.前列腺癌治疗抵抗的特征分析。
Int J Mol Sci. 2018 Mar 19;19(3):904. doi: 10.3390/ijms19030904.
雄激素受体共抑制因子与前列腺癌
Endocr Relat Cancer. 2006 Dec;13(4):979-94. doi: 10.1677/erc.1.01115.
4
Male germ cell-associated kinase, a male-specific kinase regulated by androgen, is a coactivator of androgen receptor in prostate cancer cells.雄性生殖细胞相关激酶是一种受雄激素调节的雄性特异性激酶,它是前列腺癌细胞中雄激素受体的共激活因子。
Cancer Res. 2006 Sep 1;66(17):8439-47. doi: 10.1158/0008-5472.CAN-06-1636.
5
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.TMPRSS2:ERG融合相关缺失为深入了解前列腺癌的异质性提供了线索。
Cancer Res. 2006 Sep 1;66(17):8337-41. doi: 10.1158/0008-5472.CAN-06-1482.
6
The changing face of prostate cancer.前列腺癌不断变化的面貌。
J Clin Oncol. 2005 Nov 10;23(32):8146-51. doi: 10.1200/JCO.2005.02.9751.
7
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.前列腺癌中TMPRSS2与ETS转录因子基因的反复融合
Science. 2005 Oct 28;310(5748):644-8. doi: 10.1126/science.1117679.
8
Interaction of beta-catenin and TIF2/GRIP1 in transcriptional activation by the androgen receptor.β-连环蛋白与TIF2/GRIP1在雄激素受体介导的转录激活中的相互作用。
J Biol Chem. 2005 Nov 11;280(45):37853-67. doi: 10.1074/jbc.M503850200. Epub 2005 Sep 1.
9
Androgen receptor-dependent PSA expression in androgen-independent prostate cancer cells does not involve androgen receptor occupancy of the PSA locus.雄激素非依赖性前列腺癌细胞中雄激素受体依赖性前列腺特异性抗原(PSA)的表达并不涉及雄激素受体对PSA基因座的占据。
Cancer Res. 2005 Sep 1;65(17):8003-8. doi: 10.1158/0008-5472.CAN-04-3679.
10
Cancer incidence and mortality in Europe, 2004.2004年欧洲的癌症发病率和死亡率
Ann Oncol. 2005 Mar;16(3):481-8. doi: 10.1093/annonc/mdi098. Epub 2005 Feb 17.